Paul Pospisil is a Senior Client Partner in Biotechnology & Pharmaceuticals at Korn Ferry. Prior to joining Korn Ferry, Dr. Pospisil was a co-founder and managing partner of both Aduro Capital LLC, an investment management company focused on the public healthcare sector and Aduro Partners LLC, an advisory firm focused on helping venture-backed and public life science companies assess, evaluate, partner opportunities and build businesses. Previously, he was a partner in life science investments at Atlas Venture and earlier was with Millennium Pharmaceuticals, where his last position was director, strategy leadership. Earlier, he was a new product manager at Altus Biologics, a spin-out of Vertex Pharmaceuticals. Dr. Pospisil holds a doctor of philosophy in organic chemistry from Harvard University and a bachelor’s degree in biochemistry from New York University. He also attended Harvard Business School’s Program for Management Development (PMD). Dr. Pospisil is an American Chemical Society Member since 1989 and an active Board Member of Société de Chimie
